Skip to main content

Table 2 Maximum and week 12 acute GU and GI toxicity

From: A randomized hypofractionation dose escalation trial for high risk prostate cancer patients: interim analysis of acute toxicity and quality of life in 124 patients

Group

 

    Max GU toxicity

   

  Max GI toxicity

 

Grade

0

1

2

3

0

1

2

3

Arm 1

 

10 (18%)

31 (54%)

12 (21%)

4 (7%)

16 (28%)

18 (32%)

23 (40%)

0 (0%)

Arm 2

 

8 (12%)

43 (64%)

11 (16%)

5 (7%)

17 (25%)

24 (36%)

26 (39%)

0 (0%)

Fisher’s test p

NS

NS

NS

NS

NS

NS

NS

-

  

 GU toxicity at week 12

   

GI toxicity at week 12

 

Arm 1

 

28 (55%)

21 (41%)

2 (4%)

0 (0%)

36 (71%)

8 (16%)

7 (13%)

0 (0%)

Arm 2

 

46 (85%)

7 (13%)

1 (2%)

0 (0%)

48 (89%)

4 (7%)

2 (4%)

0 (0%)

Fisher’s test p

0.001

0.002

NS

-

0.027

NS

NS

-

  1. Abbreviations: Arm 1 = conventional fractionation; Arm 2 = hypofractionation; NS = difference not significant (p < 0.05).